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Fib r in degradation products ( F D P ) increase in serum and urine of nephro-
pathy patients is already established by series of investigators (3 , 8—10). The 
study of these products possesses a definite importance for the evaluation of the 
severity of the disease as wel l as for the necessity of anticoagulation therapy 
(11 , 12). There are a few of observations in this relation when chronic renal fai-
lure ( C R F ) is concerned (15). The contingents included commonly patients wi th 
different primary diseases causing the appearance of renal insufficiency. Thus 
proceeding from the literature data we set us the task of examining F D P level in 
various C R F degrees resulted from chronic pyelonephritis only. 
Material and methods 
The study covered 44 C R F patients divided according to the degree of renal 
insufficiency into the following groups: 1 s t — in i t i a l — 18 patients; 2 n d — ex-
pressed— 14, and 3 r d — advanced—12 . Selection was made after Razboyni-
kov-Mushmov's classification (6). C R F was the result of chronic pyelonephritis 
diagnosticated on the basis of the main c l in ica l and paracl inical cr i ter ia of the 
disease (7). The control group consisted in 35 c l in ica l ly healthy individuals in 
an almost equal age group as compared wi th the C R F patients 
Serum F D P were determined by using of Merskey's et a l . (1966) immunolo-
gical test, soluble fibrin monomeric complexes (FMC) in plasma after L i p i n s k i ' s 
et a l . (1968) method and blood f ibrinolyt ic ac t iv i ty ( F A ) by means of euglobuli-
nolysis (4). Routine coagulation parameters (fibrinogen, blood platelets, pro-
thrombin ac t iv i ty , bleeding and coagulation time) were also examined. 
\ Results and discussion 
Our results showed an increase of both F D P and F M C . Thei r changes were 
more significant w i th advancing renal insufficiency. Mean rates of aforementi-
oned indices differed stat is t ical ly rel iably from these of the controls (table 1). 
The correlation analysis concerning these diseases demonstrated a strongly 
positive correlation between F D P and F M C wi th coefficient of 0.7432. There was a 
moderately positive relationship of F D P and urea (r—0.4562) and F D P and crea-
tinine ( r=0.4374) . The frequency of increased F D P wi th 1 s t degree C R F was 38.8 
per cent, wi th 2 n d one — 57.7 per cent, and wi th 3 r d one — even 66.6 per cent of 
the cases. I n some patients tending to nitrogen fraction reduction in the course 
of treatment there was also a decrease of F D P and F M C both, however, s t i l l in 
the range of levels differing stat is t ical ly significantly from these of the controls. 
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T a b l e I 
Examined parameters in C R F patients 
Parameters/ FDP mg/l F D P (0U> FA (min) 
Groups x±A x±A x±A 
healthy 3.468-0.429 0 .З6З-Э.041 223.626=1=1 1.850 
C R F 11.310^=4.803 0.445-0.099 232.722=1=15.710 
1 s t degree p<0.001 p<0,02 p<0 .05 
C R F 15.860=1=7.426 0.552—Э. 107 239.285=1=19.211 
2 n d degree p<0.001 P<1Q01 p<0.02 
C R F 22.891 =t 13.264 0 .641-0.124. 261.266=1=31.631 
3 r d degree p<0.01 p<0.001 p<0.01 
The rates of these parameters were as followed: 1 s t degree C R F : F D P 6.062 = 
1.616 mg/1 (p<0.01) and F M C 0.445=0.062 U (p<0,01) ; 2 n d degree C R F : F D P 
10.531=4.103 mg/1 (p<0.01) and F M C 0.505=0.082 U (p<0.01) ; 3 r d degree C R F : 
F D P 14.027=7.36 mg/1 (p<0.01) and F M C 0.531=0.120 U (p<0.01) . 
F A showed a stat is t ical ly reliable time elongation as compared wi th that of 
the healthy individuals (table 1). The correlation between F D P and F A was mo­
derately positive wi th a coefficient of 0.4015. 
Fibrinogen concentration increased significantly in a l l C R F degrees as fol­
lowed: 1 s t degree — 4.487=0.56 g/l (p<0.001); 2 n d degree— 4.763=0.821 g/1 
(p<0.001) , and 3 r d degree — 4.677=0.678 g/l (p<0,001) . Th i s index was 2.977 = 
0.154 g/l in the control group. 
There was, therefore, a parallel ism between F D P concentration and frequ­
ency of increase, on the one hand, and the severity of renal insufficiency in diffe­
rent C R F stages, on the other. Diminut ion of nitrogen fractions induced a reduc­
tion of the level of this index. The positive correlation between F D P , on the one 
hand, and urea creatinine, on the other, argued also for this statement. Our ob­
servations were in concordance wi th Hedner's et a l . (1973) data. The increased 
fibrinogen concentration reported by ourselves confirmed the investigations of 
other authors, too ( 1 , 2) . 
F A in the circulation was suppressed in C R F patients (2, 5) . Th i s fact could 
be due to the increased ac t iv i ty of fibrinolysis inhibitors. The time elongation of 
euglobulinolysis as established in our study did not allow us, however, to af­
f i rm emphatically that there was F A depression wi th these cases because by using 
of this method an information was provided about fibrinolysis activators only 
and inhibitor influences were ignored. 
F D P enhancement in C R F despite of F A depression in the common ci rcu­
lat ion could be due most l ike ly to local f ibr inolyt ic processes resulted from renal 
intravascular coagulation. Our assumption is confirmed by the strongly positive 
correlation between F D P and F M C found out in this study. 
On the basis of our own observations we can consider blood F D P increase in 
C R F most probably a result from secondary f ibr inolysis . The level of these pro­
ducts rises wi th advancing renal insufficiency and correlates wi th that one of serum 
urea and creatinine. 
Changes of the serum fibrin. . 
И З М Е Н Е Н И Я У Р О В Н Я С Ы В О Р О Т К И Ф И Б Р И Н Д Е Г Р А Д Л Ц И О Н Н Ы Х 
П Р О Д У К Т О В ( Ф Д П ) У Б О Л Ь Н Ы Х Х Р О Н И Ч Е С К И Й П И Е Л О Н Е Ф Р И Т О М 
В С Т А Д И И Х Р О Н И Ч Е С К О Й П О Ч Е Ч Н О Й Н Е Д О С Т А Т О Ч Н О С Т И ( Х П Н ) 
Р . Ллахвердян 
Р Е З Ю М Е 
Исследованы фибриндеградационные продукты, растворимые фибринмономерные ком­
плексы и эуглобулиновый лизис (как метод для определения фибринолитической активности 
крови) у больных с начальной, выраженной и далеко зашедшей почечной недостаточностью, 
наступившей в результате хронического пиелонефрита. Устанавливается, что с прогресси-
рованием почечной недостаточности параллельно возрастает и количество фибриндеграда-
ционных продуктов и фибринмономерных комплексов. Стоимости этих показателей по­
казывают статистически значимую разницу по сравнению с показателями исследования 
клинически здоровых людей. У больных, при которых отмечается тенденция к снижению 
азотистых фракций в результате лечения основного заболевания, устанавливается т а к ж е 
уменьшение количества фибриндеградационных продуктов. 
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